Valmet (VALMT) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
16 Mar, 2026Unique and comprehensive market offering
Broadest portfolio in the market, covering pulp, energy, circularity, packaging, paper, tissue, automation, and flow control solutions.
Extensive biomaterial services including spare parts, maintenance, process support, and outsourcing.
Advanced automation solutions with distributed control, quality management, analyzers, and industrial internet capabilities.
Strong global market positions
Holds #1 or #1-2 positions in pulp, paper, tissue, renewable energy, and related services.
Maintains leading positions in automation and flow control across multiple industries.
Proven growth and financial performance
Orders received grew from €3.1B in 2014 to €5.8B in 2025; net sales rose from €2.5B to €5.2B in the same period.
Comparable EBITA margin reached 11.9% in 2025, with a backlog of €4.3B and 18,487 employees.
Biomaterial services achieved 6% organic net sales CAGR (2017–2025) and 21% market share.
Latest events from Valmet
- Orders up 27%, stable profit, and restructuring targets EUR 80m in savings by 2026.VALMT
Q1 20258 Jul 2026 - Record orders of EUR 5.8B in 2024, with stable sales, earnings, and strong cash flow.VALMT
Q4 20248 Jul 2026 - Record EBITDA margin, stable dividend, and new strategy approved amid sustainability focus.VALMT
AGM 202630 Jun 2026 - Orders down 15–18%, net sales up 5%, margin pressured by mix; 2026 guidance unchanged.VALMT
Q1 202628 Apr 2026 - Record profitability and stable outlook with strong cash flow and €1.35 dividend proposed.VALMT
Q4 20256 Feb 2026 - Q2 orders steady, EBITA down, 2024 EBITA outlook raised despite higher net debt.VALMT
Q2 20243 Feb 2026 - Record Q3 margin and major order offset weak market; 2024 outlook stable.VALMT
Q3 202417 Jan 2026 - Operating model overhaul targets EUR 80m savings and 1,150 role reductions for greater efficiency.VALMT
Investor Update26 Dec 2025 - Targets 5% organic growth, 15% EBITDA/EBITA, and 20% ROCE by 2030 with lifecycle and digital focus.VALMT
CMD 202520 Nov 2025